Impact of Dopamine Infusion on Insulin Secretion in Healthy Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

15

Participants

Timeline

Start Date

December 31, 2013

Primary Completion Date

January 31, 2016

Study Completion Date

January 31, 2016

Conditions
HyperglycemiaSepsis
Interventions
DRUG

Dopamine

Each subject will receive a priming dose of dextrose 20% to increase their glucose concentration by 125 mg/dl in the first 15 minutes. Then they will receive variable rates of dextrose 20% infusion to maintain glucose level at 180-220 mg/dl. Then, dopamine (200mg/250ml) will be titrated up to 5 mcg/kg/min with care not to increase blood pressure greater than 160 systolic. Dopamine will be infused for 3 hours.

Trial Locations (1)

10467

Montefiore Medical Center of Albert Einstein College of Medicine, The Bronx

All Listed Sponsors
lead

Albert Einstein College of Medicine

OTHER

NCT02053935 - Impact of Dopamine Infusion on Insulin Secretion in Healthy Subjects | Biotech Hunter | Biotech Hunter